Clinical trial
Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa
NCT00100646 · The Wistar Institute, Other · Completed
Key facts
| NCT number | NCT00100646 |
|---|---|
| Title | Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa |
| Official title | A Randomized Clinical Trial Assessing Continuous HAART Versus Interrupted HAART in a Resource Poor Clinic |
| Lead sponsor | The Wistar Institute, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral, Biological, Drug |
| Interventions | Structured treatment interruption, Lamivudine, Lopinavir/Ritonavir, Stavudine, Rabies de novo antigen |
| Enrollment | 30 |
| Start date | Mar 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Jan 5, 2005 |
| Last update posted | Aug 27, 2014 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: